Cohen & Steers, Inc.
NYSE:CNSAsset Management
+$0.63 today
- Market cap
- $3.45B
- Beta
- 1.23
- P/E (TTM)
- 24.8
- EPS (TTM)
- $3.03
- Dividend yield
- 3.44%
Volume 0.39M
Average 0.32M
CNS Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Cohen & Steers, Inc.NYSE: CNS
Other Income / Expenses · Q3 FY2026 · quarter ended Sep 2026
Other income / expenses declines year over year
Q3 FY2026 other income / expenses of $6.25M fell 6.1% year over year, ahead of the -38.2% change in trailing-twelve-month other income / expenses. Sequentially, it rose 23.8% from the prior quarter.
Context
- Other income / expenses amounted to 4.7% of revenue in FY2025, down 2.3 pp from a year earlier.
- Other income / expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -6.1% holds above the trailing-twelve-month pace of -38.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 26.89M USD
- Year-over-year change
- -26.6%
- 4-year CAGR
- +5.7%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.89M | -26.6% |
| FY2024 | 2024-12-31 | 36.66M | +132.4% |
| FY2023 | 2023-12-31 | 15.77M | +182.8% |
| FY2022 | 2022-12-31 | (19.04M) | -188.3% |
| FY2021 | 2021-12-31 | 21.57M | — |
Other Income / Expenses vs competitors
How CNS compares with its peers on the latest reported figures
- CNS's LTM Sep 2026 other income / expenses of $19.35M is the 4th highest of the 10 companies compared; the peer median is $0.
- Its year-over-year change of -38.2% is the 4th highest of 7, against a peer median of -39.6%.
- Other income / expenses amounts to 3.2% of revenue for CNS, versus a peer median of 8.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $154.65M | -37.0% | — | 33.4% | |
| LTM Sep 2026 | $48.87M | -36.9% | — | 3.9% | |
| LTM Jun 2026 | $28.49M | -7.4% | — | 1.5% | |
| LTM Sep 2026 | $19.35M | -38.2% | — | 3.2% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | -$53.56M | — | — | 9.2% | |
| LTM Sep 2026 | -$138.82M | -232.6% | — | 8.7% | |
| LTM Sep 2026 | -$313.82M | -42.1% | — | 47.0% | |
| LTM Sep 2026 | -$520M | -2160.9% | — | 57.9% | |
| Peer median (excluding CNS) | $0 | -39.6% | — | 8.7% | |
Competitors are the stored peer set for CNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 583.83M | 573.72M | 489.64M | 517.42M | 567.8M |
| Cost of Revenue | 271.33M | 291.76M | 254.35M | 275.12M | 241.28M |
| Gross Profit | 312.5M | 281.97M | 235.29M | 242.3M | 326.52M |
| Gross Margin | 53.5% | 49.1% | 48.1% | 46.8% | 57.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.03M | 54.83M | 66.7M | 60.14M | 71.23M |
| Operating Expenses | 52.13M | 66.03M | 70.81M | 69.42M | 148.78M |
| Depreciation & Amortization | 16.03M | 5.67M | 5.14M | 11.17M | 11.71M |
| EBITDA | 279.28M | 228.42M | 169.62M | 203.39M | 201.14M |
| EBITDA Margin | 47.8% | 39.8% | 34.6% | 39.3% | 35.4% |
| Operating Income | 260.37M | 215.94M | 164.48M | 172.88M | 177.74M |
| Operating Margin | 44.6% | 37.6% | 33.6% | 33.4% | 31.3% |
| Interest Income | 2.88M | 6.82M | 14.62M | 19.34M | 10.32M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 21.57M | (19.04M) | 15.77M | 36.66M | 26.89M |
| Income Before Tax | 281.94M | 196.9M | 180.25M | 209.54M | 204.63M |
| Pre-Tax Margin | 48.3% | 34.3% | 36.8% | 40.5% | 36.0% |
| Income Tax Expense | 55.79M | 47.41M | 43.64M | 46.75M | 47.23M |
| Net Income | 211.4M | 171.04M | 129.05M | 151.27M | 153.22M |
| Net Margin | 36.2% | 29.8% | 26.4% | 29.2% | 27.0% |
| EPS (Basic) | 4.38 | 3.51 | 2.62 | 3.00 | 2.99 |
| EPS (Diluted) | 4.31 | 3.47 | 2.60 | 2.97 | 2.98 |
| Weighted Avg Shares | 48.32M | 48.78M | 49.31M | 50.41M | 51.24M |
| Weighted Avg Shares (Diluted) | 49.09M | 49.3M | 49.55M | 50.94M | 51.64M |
Cohen & Steers, Inc.
NYSE:CNS
Intrinsic Alpha fair value
Locked
Current Price
$67.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.